Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

PerkinElmer acquires SimoTech for automation solutions

PRIVATESep 03, 2026•3 days ago

Acquiring Company

PerkinElmer

Acquired Company

SimoTech

SheltonIrelandManufacturingInformation TechnologyBiotechnology

Description

PerkinElmer has completed its acquisition of SimoTech, enhancing its solutions for the life sciences industry. This acquisition will combine SimoTech's manufacturing automation expertise with PerkinElmer's integrated laboratory solutions. The collaboration aims to accelerate drug development and improve operational performance in the pharmaceutical sector. Both companies are poised to offer greater value to clients and unlock new growth opportunities.

Company Information

Company

PerkinElmer

Location

Shelton, Connecticut, United States

About

PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life science, food, and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the well-being and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com. About BioLegend BioLegend enables life science discovery from research to cure by providing world-class, cutting-edge antibodies and reagents for biomedical research, manufactured in its state-of-the-art facility in San Diego, CA. Its mission is to accelerate research and discovery by providing the highest quality products at an outstanding value, along with superior customer service and technical support. Its product expertise covers a diverse set of research areas including Immunology, Neuroscience, Cancer, Stem cells, and Clinical Products. BioLegend’s reagents are supported by superior customer service and a quality management system that is certified for ISO 13485:2016. With a strong commitment to the scientific community, BioLegend pushes the boundaries of scientific innovation, and transforms the way we collect and interpret scientific knowledge. To learn more, visit www.biolegend.com.

Don't miss PerkinElmer's next move

Get an email the moment PerkinElmer makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for PerkinElmer's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired SimoTech?

SimoTech was acquired by PerkinElmer, based in Shelton. The deal was reported on September 3, 2026. PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. PerkinElmer is privately held.

When did PerkinElmer acquire SimoTech?

PerkinElmer's acquisition of SimoTech was reported on September 3, 2026. PerkinElmer has completed its acquisition of SimoTech, enhancing its solutions for the life sciences industry. This acquisition will combine SimoTech's manufacturing automation expertise with PerkinElmer's integrated laboratory solutions. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does SimoTech do?

SimoTech is a trusted provider of manufacturing automation and GMP IT solutions to the life sciences industry. Founded in 2011, it has become a leading automation technology services provider supporting major pharmaceutical and biotechnology companies. It is privately held, operating in Manufacturing, and is based in Ireland.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.